Clinical Trial Update: Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ridaforolimus in recurrent/metastatic and locally advanced endometrial cancer completes enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Ridaforolimus (ridaforolimus)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED